» Articles » PMID: 11736700

Brain MR Perfusion Imaging in Humans

Overview
Journal Acta Radiol
Specialty Radiology
Date 2001 Dec 12
PMID 11736700
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate any possible advantages of high-concentration gadolinium chelates in the human brain thin-slice MR.

Material And Methods: Thirty-six patients were allocated into six groups. Three groups had perfusion imaging performed using 7-mm-thick slices and the other three groups had 4-mm-thick slices. One group who had 7-mm slices and one group of 4-mm slices had 0.5 M gadolinium (20 ml) whilst other groups received the high-concentration gadolinium (1.0 M: 10 ml and 20 ml). The time-intensity curves were analysed for maximum signal reduction and signal-to-noise measurements.

Results: Twenty ml of the 1.0-M agent produced significantly increased maximum signal change and improvement in signal-to-noise when compared to 20 ml of 0.5 M. There was no significant difference between the maximum signal change when 20 ml of 0.5 M and 10 ml of 1.0 M agents were compared. There was no significant difference between the maximum signal changes when 7-mm and 4-mm slice thickness using the same dosing regimens.

Conclusion: Four-mm slice thickness perfusion imaging can be performed with high-concentration gadolinium in the human brain and we discuss the advantages of this.

Citing Articles

Dynamic susceptibility MR perfusion imaging of the brain: not a question of contrast agent molarity.

Panara V, Chiacchiaretta P, Rapino M, Maruotti V, Parenti M, Piccirilli E Neuroradiology. 2021; 64(4):685-692.

PMID: 34557937 DOI: 10.1007/s00234-021-02807-7.


Cerebral blood volume mapping with ferumoxytol in dynamic susceptibility contrast perfusion MRI: Comparison to standard of care.

Varallyay C, Nesbit E, Horvath A, Varallyay P, Fu R, Gahramanov S J Magn Reson Imaging. 2018; 48(2):441-448.

PMID: 29314418 PMC: 6034979. DOI: 10.1002/jmri.25943.


Comparison of normal facial nerve enhancement at 3T MRI using gadobutrol and gadopentetate dimeglumine.

Radhakrishnan R, Ahmed S, Tilden J, Morales H Neuroradiol J. 2017; 30(6):554-560.

PMID: 28696161 PMC: 5703139. DOI: 10.1177/1971400917719714.


Gadolinium contrast agents for CNS imaging: current concepts and clinical evidence.

Kanal E, Maravilla K, Rowley H AJNR Am J Neuroradiol. 2014; 35(12):2215-26.

PMID: 24852287 PMC: 7965302. DOI: 10.3174/ajnr.A3917.


Absolute quantification of perfusion using dynamic susceptibility contrast MRI: pitfalls and possibilities.

Knutsson L, Stahlberg F, Wirestam R MAGMA. 2009; 23(1):1-21.

PMID: 19960361 DOI: 10.1007/s10334-009-0190-2.